GWANC
VRTX icon

Guardian Wealth Advisors (North Carolina)’s Vertex Pharmaceuticals VRTX Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522K Sell
1,051
-2
-0.2% -$886 0.03% 228
2026
Q1 		$470K Hold
1,053
– – 0.03% 225
2025
Q4 		$477K Buy
1,053
+2
+0.2% +$862 0.03% 220
2025
Q3 		$411K Sell
1,051
-1
-0.1% -$418 0.03% 239
2025
Q2 		$468K Sell
1,052
-24
-2% -$11.1K 0.03% 205
2025
Q1 		$521K Buy
1,076
+14
+1% +$6.52K 0.04% 187
2024
Q4 		$427K Buy
1,062
+17
+2% +$7.88K 0.03% 207
2024
Q3 		$486K Hold
1,045
– – 0.05% 169
2024
Q2 		$490K Sell
1,045
-8
-0.8% -$3.47K 0.06% 160
2024
Q1 		$440K Buy
1,053
+24
+2% +$10.1K 0.05% 174
2023
Q4 		$418K Sell
1,029
-31
-3% -$11.5K 0.06% 155
2023
Q3 		$368K Buy
1,060
+13
+1% +$4.55K 0.06% 157
2023
Q2 		$368K Buy
1,047
+25
+2% +$8.42K 0.06% 154
2023
Q1 		$322K Sell
1,022
-32
-3% -$9.6K 0.06% 164
2022
Q4 		$304K Hold
1,054
– – 0.06% 152
2022
Q3 		$305K Buy
1,054
+32
+3% +$9.21K 0.06% 146
2022
Q2 		$288K Buy
1,022
+7
+0.7% +$1.87K 0.05% 151
2022
Q1 		$265K Buy
+1,015
New +$241K 0.11% 134

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s VRTX Position: Q2 2026 in Review

Guardian Wealth Advisors (North Carolina) reduced its Vertex Pharmaceuticals (VRTX) stake by 0.19% in Q2 2026, selling an estimated $886 and leaving 1,051 shares worth $522K. The position accounts for 0.03% of the portfolio, ranked #228.

Guardian Wealth Advisors (North Carolina) first reported a position in VRTX in Q1 2022 and has held it in 18 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Guardian Wealth Advisors (North Carolina) held 1,051 shares of Vertex Pharmaceuticals worth $522K as of Q2 2026.
  • Guardian Wealth Advisors (North Carolina) sold 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
  • Vertex Pharmaceuticals made up 0.03% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #228 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.